Short Term Outcome of Acute Heart Failure in Diabetic and Non Diabetic Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University

About this trial

Around 26 million people suffer from heart failure (HF) globally, and the prevalence is increasing with an increasing longevity, prevalence of risk factors, and improved survival in patients with cardiovascular diseases In Egypt, HF is the primary cause of hospitalization among patients aged \> 65 years . Hospitalization for HF is associated with a high mortality and rate of re-hospitalization . Around 75% patients with HF have ≥ 1 comorbidity, and these comorbidities make overall clinical outcomes worse . In a recent meta-analysis, patients with diabetes mellitus (DM) were suggested to have a two-fold increase in the risk of HF . DM is present in \~ 35% patients hospitalized with acute HF . Multiple factors such as ischemia, hypertension, and extracellular fluid volume expansion are involved in the pathogenesis of HF in DM.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 18 years old or older .

Admitted to the Coronary Care Unit with acute HF.

Patients with new onset heart failure.

Decompensated chronic HF.

Disqualifiers

Aged under 18 years old.

Patients with chronic HF

Trial population

* Aged 18 years old or older . * Admitted to the Coronary Care Unit with acute HF. * Patients with new onset heart failure. * Decompensated chronic HF.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • pro BNP

    Diagnostic test

    Test is mainly used to help diagnose or rule out heart failure in a person who is having symptoms

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Diabetic patients1 intervention
Group B: Non Diabetic patients1 intervention

Trial outcomes

Primary outcomes

1

Pro BNP level

A pro BNP test is mainly used to help diagnose or rule out heart failure in a person who is having symptoms

Time frame
6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.